166 - 180 of 296 Items

Research paper2023, jun 1

Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix

R Nanda, Aradhana Katke, Thejaswini B, G V Giri, Yashwant Pawar, Manjula M V, Govind Babu, Govind Babu

Vol 28, No 3 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(3):322-331.
Other materials agreed with the Editors2023, jul 6

Erratum to: Surface guided 3DCRT in deep-inspiration breath‑hold for left sided breast cancer radiotherapy: implementation and first clinical experience in Iran

Sara Abdollahi, Mohammad Hadi Hadizadeh Yazdi, Ali Asghar Mowlavi, Sofie Ceberg, Marianne Camille Aznar, Fatemeh Varshoee Tabrizi, Roham Salek, Alireza Ghodsi, Farideh Jamali

Vol 28, No 3 (2023)

Other materials agreed with the Editors

Rep Pract Oncol Radiother 2023;28(3):435-436.
Research paper2023, jun 14

Curative treatment for stage IIIC2 cervical cancer: what to expect?

Geovanne Pedro Mauro, Vinicius de Aquino Calheiros, Matheus Sorgi Vonsowski, Talita Avelar, Heloisa A. Carvalho

Vol 28, No 3 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(3):332-339.
Research paper2023, jul 6

Acute toxicity and quality of life in prostate cancer patients treated with definitive hypofractionated pelvic radiation therapy: a single-center report

Isidora Antonia King Mandel, Felipe Kovacic Diaz, Lorena Vargas Garcia

Vol 28, No 3 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(3):316-321.
Research paper2023, jul 6

Optimal values of the Electron Monte Carlo dose engine parameters

Jacek Wendykier, Ewa Wojtyna, Barbara Bekman, Adam Bekman, Bożena Woźniak, Beata Niewiadomska, Joanna Prażmowska, Piotr Wendykier, Marcin Bieniasiewicz, Aleksandra Grządziel

Vol 28, No 3 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(3):416-428.
Clinical vignette2023, jun 14

Potential use of [18F]FDG heterogeneity in discrimination of two different synchronous primary tumors

Paulina Cegla, Anna Filipczuk, Witold Cholewinski

Vol 28, No 3 (2023)

Clinical vignette

Rep Pract Oncol Radiother 2023;28(3):433-434.
Review paper2023, jul 31

Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap

Katarzyna Regulska, Marcin Michalak, Tomasz Kolenda, Joanna Kozłowska-Masłoń, Kacper Guglas, Beata Stanisz

Vol 28, No 4 (2023)

Review paper

Rep Pract Oncol Radiother 2023;28(4):551-564.
Research paper2023, jul 29

Tyrosine kinase inhibitors induced thyroid dysfunction: myth or reality?

Anjli Malhotra, Rajeev Gupta, Shveta Mahajan

Vol 28, No 4 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(4):463-467.
Research paper2023, jul 31

PRIMO Monte Carlo software as a tool for commissioning of an external beam radiotherapy treatment planning system

Juan-Francisco Calvo-Ortega, Marcelino Hermida-López

Vol 28, No 4 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(4):529-540.
Research paper2024, jan 23

Abiraterone and enzalutamide in the first line therapy of metastatic castration resistant prostate cancer

Sofya Al-Samsam, Jiří Bartoš, Vladimir Šámal, Josef Dvořák, Hana Kolářová, Igor Richter

Vol 29, No 1 (2024)

Research paper

Rep Pract Oncol Radiother 2024;29(1):1-9.
Research paper2022, aug 2

Deep inspiration breath hold in post-operative radiotherapy for right breast cancer: a retrospective analysis

Giulia Borgonovo, Eleonora Paulicelli, Deborah Daniele, Stefano Presilla, Antonella Richetti, Mariacarla Valli

Vol 27, No 4 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(4):717-723.
Review paper2023, sep 19
Research paper2023, jul 29

Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response

Alessandra Castelluccia, Domenico Marchesano, Gianmarco Grimaldi, Ivan Annessi, Federico Bianciardi, Cristian Borrazzo, Annamaria Dipalma, Randa El Gawhary, Marica Masi, Maria Rago, Maria Valentino, Laura Verna, Maurizio Portaluri, PierCarlo Gentile

Vol 28, No 4 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(4):437-444.
Research paper2023, jul 27

Hippocampal avoidance whole brain radiotherapy in brain metastasis using volumetric modulated arc therapy: experience from a Regional Cancer Centre of Eastern India

Goyel Deepsikha, Tapas Maji, Debarshi Lahiri, Sanjoy Roy, Sayoni Bhanja, Sreekrishna Rangineni, Dilip Kumar Ray, Bijan Kumar Mohanta, Dilip Kumar Misra, Palas De

Vol 28, No 4 (2023)

Research paper

Rep Pract Oncol Radiother 2023;28(4):468-477.
Review paper2023, oct 5

miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology

Joanna Kozłowska-Masłoń, Kacper Guglas, Tomasz Kolenda, Katarzyna Lamperska, Izabela Makałowska

Vol 28, No 5 (2023)

Review paper

Rep Pract Oncol Radiother 2023;28(5):681-697.